Skip to main content

Genenta Science S.p.A.

For the period ended Jul 14, 2026. Filed Jul 14, 2026.

View on SEC.gov

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

Jul 14, 2026 · Filed Jul 14, 2026

Use the contents to explore the available documents and sections.

GNTA$0.99+20.6%Stored close · as of Nov 3, 2026
See the whole filing, with its images and exhibits

Forward-Looking Statements

This Report on Form 6-K (this “Report) contains forward-looking statements involve risks and uncertainties. These statements include, but are not limited to, statements regarding the Company’s legal proceedings, business strategy, strategic initiatives, and future plans. Forward-looking statements are based on the Company’s current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks include, among others, the outcome of the pending merits proceedings and the other risks described in the Company’s filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 20-F and subsequent Reports on Form 6-K. You are cautioned not to place undue reliance on forward-looking statements, which are based on the Company’s current expectations and assumptions and speak only as of the date of this Report. The Company undertakes no obligation to update any forward-looking statements except as required by applicable law.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.